Mechelen, Belgium

Biocartis, Nv


USPTO Granted Patents = 24

% Expired Patents = 12.5



Trademarks = 3

Forward Citations = 47

Loading Chart...
Loading Chart...

54 inventors (with patents filed for the assignee):

goldMedal Ronald Cornelis De Gier (5 out of 26 patents)

silverMedal Roel Penterman (5 out of 21 patents)

bronzeMedal Michiel De Jong (3 out of 10 patents)

4.  Nicolas Vergauwe (3 out of 5 patents)

5.  Bart Van Meerbergen (3 out of 3 patents)

6.  Hendrik Halling Van Amerongen (2 out of 6 patents)

7.  Reinhold Wimberger-Friedl (2 out of 42 patents)

8.  Bart Claes (2 out of 2 patents)

9.  Geert Meersseman (2 out of 3 patents)

10.  Hannah Kenens (2 out of 2 patents)

11.  David Nauwelaers (2 out of 3 patents)

12.  Geert Maertens (2 out of 3 patents)

13.  Arie R Van Doorn (2 out of 15 patents)

14.  Paul Arnold Van De Wiel (1 out of 4 patents)

15.  Sieglinde Neerken (1 out of 5 patents)


24 patents:

Company Overview
Biocartis, based in Mechelen, Belgium, specializes in the development of innovative molecular diagnostics solutions. The company focuses on providing advanced technologies for the detection of various diseases, including cancer, through its proprietary Idylla™ platform. This platform enables rapid and accurate testing, facilitating personalized medicine approaches. Biocartis aims to enhance patient care by delivering reliable diagnostic tools that support healthcare professionals in making informed decisions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Biocartis, Nv USPTO Patent Assignee Logo
24 Patents

#2 in Mechelen

#139 in Belgium

#26,628 in the World

Mechelen, BE
Mechelen, Belgium
Forward Citations = 47

54 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biocartis, Nv. Retrieved from https://idiyas.com/company/biocartis-nv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…